Visual Neurophisiology
2025 Activity indicators
- 2 competitive national public projects: ISCIII, MINECO/MICINN
- 5 publications · Impact Factor: 31.70
- Publications in Q1: 4 (80%)
- Publications in D1: 3 (60%)
- 1 supervised doctoral thesis defended
- Evaluators of national public agency projects: 1 PI
- Editorial committee members: 1 PI
- 2 actions with social impact: one conference and one participation in a roundtable discussion
Milestones
- Identification of new therapeutic targets in neurodegeneration through drug repositioning strategies and the study of molecular mechanisms involved in dopaminergic signaling.
- Strengthening the role of the visual system, and in particular the retina, as an accessible platform for the development of functional biomarkers applicable to neurodegenerative diseases.
- Development and validation of new approaches based on visual electrophysiological techniques, with potential application in the diagnosis and clinical monitoring of ocular pathologies.
- Contribution to the development and preclinical evaluation of new therapeutic strategies for degenerative retinal diseases, including innovative compounds with functional and structural effects.
- Joint organization, in collaboration with the Ophthalmology Department of the Ramón y Cajal University Hospital, of the 9th International Congress on Retina and Vision Research (SIREV 2025), consolidating the group's position in the field of vision research and fostering scientific collaboration.
Bibliometrics
| ARTICLES | ACCUM. IF | MEAN IF | ARTICLES Q1 OR Q2 | % IN Q1 OR Q2 | ARTICLES D1 | % IN D1 | |
|---|---|---|---|---|---|---|---|
| 2021 | 8 | 50.32 | 6.29 | 8 | 100 | 1 | 15 |
| 2022 | 7 | 61.88 | 8.84 | 7 | 100 | 1 | 14 |
| 2023 | 6 | 41.61 | 6.94 | 6 | 100 | 3 | 50 |
| 2024 | 9 | 30.40 | 3.38 | 7 | 78 | 0 | 0 |
| 2025 | 5 | 31.70 | 6.34 | 5 | 100 | 3 | 60 |
| 35 | 215.91 | 6.36 | 33 | 96 | 8 | 27 |
* Only original articles, editorial material, guidelines and reviews.